AXT is trading up 4.06% at $54.20 on October 26, as Wedbush says it could beat Wall Street’s Q3 estimates ahead of its October 29 report.
- Wedbush views AXT’s roughly $66 million revenue outlook as a floor, citing supportive demand and rising indium phosphide pricing; capacity and pricing shape any beat.
- AXT rebounded after a 13.02% October 22 fall; U.S. indexes are higher. Wedbush’s same-day note was the clearest company-specific catalyst; volume was unreported, preventing normal-activity comparison.